title: Hysterosalpingography for assessing efficacy of Essure microinsert permanent birth control device.
abstract: OBJECTIVE
  The Essure microinsert is a new U.S. Food and Drug Administration-approved method of birth control. The objective of this study is to report our initial experience using hysterosalpingography (HSG) to assess its efficacy for permanent tubal occlusion.
  
  
  CONCLUSIONS
  The Essure microinsert produced tubal blockage in all patients. As this device may become more widely used, radiologists should be aware of the device's appearance and be able to assess device position and presence of tubal occlusion on HSG.
authors.affiliation: Department of Radiology, Mayo Clinic, 200 1st St., SW, Rochester, MN 55902, USA.
authors.forename: Michael H
authors.initials: MH
authors.lastname: Wittmer
authors.forename: Abimbola O
authors.initials: AO
authors.lastname: Famuyide
authors.forename: Douglas J
authors.initials: DJ
authors.lastname: Creedon
authors.forename: Robert P
authors.initials: RP
authors.lastname: Hartman
mesh_terms: D000328:Adult; D003274:Contraceptive Devices, Female / Q000009:adverse effects; D005187:Fallopian Tubes; D005260:Female; D006801:Humans; D007047:Hysterosalpingography; D008875:Middle Aged; D019736:Prostheses and Implants; D013246:Sterilization, Tubal / Q000295:instrumentation*